Navigation Links
GeneNews' Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
Date:8/29/2007

- Text provides cardiologists with an overview of cardiovascular genetics

and genomics -

TORONTO, Aug. 29 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing patient-friendly blood-based biomarker tests for the detection and staging of virtually any disease or medical condition, today announced that its co-founder and Chief Scientist Dr. C.C. Liew, has co-edited a newly published genomics reference book entitled Cardiovascular Genetics and Genomics for the Cardiologist. The text provides cardiologists with an overview of cardiovascular genetics and genomics, which have been changing the fundamental understanding of cardiovascular disease and the practice of cardiovascular medicine.

"We are very proud of our Chief Scientist and the inventor of our core technologies, Dr. C.C. Liew. This is not only a significant achievement for Dr. Liew, but also an important and notable contribution to both the field of disease-specific genomics and the field of cardiovascular medicine," said K. Wayne Marshall, MD, PhD, President and Chief Executive Officer of GeneNews. "Dr. Liew is truly a pioneer in disease-specific genomics and has earned a global reputation for his outstanding scientific contributions in this cutting-edge area of healthscience."

Dr. Liew currently holds the positions of Visiting Professor of Medicine and Founding Director of the Cardiovascular Genome Unit at Brigham and Women's Hospital, Harvard Medical School, and Professor Emeritus at the University of Toronto. Genetics and Genomics for the Cardiologist is currently available from the publisher, Blackwell Publishing Inc. (http://www.blackwellcardiology.com).

About GeneNews

--------------

GeneNews is focused on the application of functional genomics to enable early diagnosis and personalized therapeutic intervention based on disease-specific biomarkers. The Company has developed a novel approach, the Sentinel Principle(TM), to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle(TM) in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews' first product in development, ColonSentry(TM), is a convenient and patient-friendly blood-based biomarker test that can detect colon cancer. For more information on GeneNews, visit http://www.genenews.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE GeneNews Limited
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. State technology chief endorses IT audit recommendations
2. Fusion 2007: CA chief says IT complexity raises risk
3. Web-Based Learning Developed under new Chief Education Officer
4. UW computer scientists fighting computer virus "Cold War"
5. UW scientist, former WiCell director found stem cell company
6. Scientists find way to make human collagen in lab
7. Wisconsin scientists to be recognized for innovative biofuel technology
8. UW biophysical scientist honored as society fellow
9. UW scientist wins Pew grant to study little-known immune cells
10. UW-Madison scientists to mimic nature for newest cancer drugs
11. The Scientist magazine names Madison "hotspot" for biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... -- Scientific Analytics, Inc.,s DARI Motion Health is one of the ... healthcare providers at Premier Inc.,s 2017 Breakthroughs Conference and ... Motion Health was debuted during the conference,s annual Innovation ... industry suppliers committed to innovation and improving patient outcomes. ... ...
(Date:6/28/2017)... ... June 28, 2017 , ... Alevio, LLC ( http://www.aleviospine.com ... 500th case using the SiCure Sacroiliac Joint Fusion System. , SiCure is a ... can be implanted in either a lateral or posterior approach, and is indicated ...
(Date:6/28/2017)... New York and London, June 28, 2017 (PRWEB) , ... ... ... The latest release of Siemens’ STAR-CCM+® software for multiphysics ... features which enable automated product design exploration and optimization. STAR-CCM+ version 12.04 ...
(Date:6/27/2017)... ... June 27, 2017 , ... The recent vote by the ... a disease gives new hope to patients and hopefully sheds new light on the ... M.D. , an infertility expert and founding partner of Texas Fertility Center . ...
Breaking Biology Technology:
(Date:6/14/2017)... PARIS , June 15, 2017  IBM (NYSE: IBM ... the international tech event dedicated to developing collaboration between startups ... on June 15-17. During the event, nine startups will ... deliver value in various industries. ... in the international market, with a 30 percent increase in ...
(Date:4/24/2017)... , April 24, 2017 Janice ... partner with  Identity Strategy Partners, LLP (IdSP) , ... or without President Trump,s March 6, 2017 ... Entry , refugee vetting can be instilled with greater ... (Right now, all refugee applications are suspended by ...
(Date:4/13/2017)... India , April 13, 2017 According to ... Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, ... MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 Billion ... Growth Rate (CAGR) of 17.3%. ... MarketsandMarkets ...
Breaking Biology News(10 mins):